Expression of oxidative stress-related molecules in circulating leukocytes and urine in patients with chronic viral hepatitis

Liver International

Volumn 26, Issue 2, 2006, Pages 157-165

  Saeki, Toshiya ^a   Ichiba, Miho ^a   Tanabe, Naotada ^a   Ueki, Masaru ^b   Okamoto, Kinya ^b   Matsunaga, Yoshiko ^b   Hosho, Keiko ^b   Kanbe, Takamasa ^a,b   Tsuchiya, Hiroyuki ^a   Kurimasa, Akihiro ^a   Yamada, Sadako ^b   Hirooka, Yasuaki ^c   Hisatome, Ichiro ^a   Kishimoto, Yukihiro ^d   Suou, Takeaki ^b   Murawaki, Yoshikazu ^b   Kawasaki, Hironaka ^d   Yodoi, Junji ^e   Shiota, Goshi ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c Department of Surgery   (Japan)

^d SAN IN ROSAI HOSPITAL   (Japan)

^e KYOTO UNIVERSITY   (Japan)

Author keywords

Antioxidant protein; Chronic viral hepatitis; Leukocyte; Lipid peroxidation

Indexed keywords

4 HYDROXY 2 HEXENAL; 4 HYDROXYNONENAL; 8 HYDROXYDEOXYGUANOSINE; ALANINE AMINOTRANSFERASE; ALDEHYDE; ASPARTATE AMINOTRANSFERASE; BETA ACTIN; CATALASE; GLUTATHIONE PEROXIDASE 1; SUPEROXIDE DISMUTASE; THIOREDOXIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; UPREGULATION; URINALYSIS; URINARY EXCRETION; URINE LEVEL; VIRUS HEPATITIS; WESTERN BLOTTING;

AGED; ALANINE TRANSAMINASE; ALDEHYDES; ASPARTATE AMINOTRANSFERASES; BLOTTING, WESTERN; DEOXYGUANOSINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; ENZYMES; FEMALE; HEPATITIS, VIRAL, HUMAN; HUMANS; LEUKOCYTES; LIPID PEROXIDATION; LIVER; MALE; MIDDLE AGED; OXIDATIVE STRESS; THIOREDOXIN; UP-REGULATION;

EID: 33646007020     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2005.01213.x     Document Type: Article

References (34)

1. Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutation Res 1997; 387: 147-63.
2. Shimoda R, Nagashima M, Sakamoto M, Yamaguchi N, Hirohashi S, Yokota J, et al. Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis. Cancer Res 1994; 54: 3171-2.
3. Farinati F, Cardin R, De Maria N, Della Libera G, Marafin C, Lecis E, et al. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol 1995; 22: 449-56.
4. De Maria N, Colantoni A, Fagiuoli S, Liu G J, Rogers B K, Farinati F, et al. Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radic Biol Med 1996; 21: 291-5.
5. Ichiba M, Maeta Y, Mukoyama T, Saeki T, Yasui S, Kanbe T, et al. Expression of 8-hydroxy-2′-deoxyguanosine in chronic liver disease and hepatocellular carcinoma. Liver Int 2003; 23: 338-45.
6. Kasai H, Nishimura S. Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acids Res 1984; 12: 2137-45.
7. Floyd R A, West M S, Eneff K L, Hogsett W E, Tingey D T. Hydroxyl free radical mediated formation of 8-hydroxyguanosine in isolated DNA. Arch Biochem Biophys 1988; 262: 266-72.
8. Kamimura S, Gaal K, Britton R S, Bacon B R, Triadaifilopoulos G, Tsukamoto H. Increased 4-hydroxynonenal levels in experimental alcoholic liver disease: Association of lipid peroxidation with liver fibrogenesis. Hepatology 1992; 16: 448-53.
9. Parola M, Pinzani M, Casini A, Albano E, Poli G, Gentilini A, et al. Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen a1(I) gene expression in human liver fat-storing cells. Biochem Biophys Res Commun 1993; 194: 1044-50.
10. Bacot S, Bernoud-Hubac N, Baddas N, Chantegrel B, Deshayes C, Doutheau A, et al. Covalent binding to hydroxyl-alkenals 4-HDDE, 4-HHE, and 4-HNE to ethanolamine phospholipids subclasses. J Lipid Res 2003; 44: 917-26.
11. Guichardant M, Chantegrel B, Deshayes C, Doutheau A, Moliere P, Lagarde M. Specific markers of lipid peroxidation issued from n-3 and n-6 fatty acids. Biochem Soc Trans 2004; 32: 139-40.
12. Yamagami K, Yamamoto Y, Kume M, Ishikawa Y, Yamaoka Y, Hiai H, et al. Formation of 8-hydroxy-2′-deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins in rat liver after ischemia-reperfusion: Distinct localization of the two oxidatively modified products. Antioxidants Redox Signal 2000; 2: 127-36.
13. Mahmood S, Kawanaka M, Kamei A, Izumi A, Nakata K, Niyama G, et al. Immunohistochemical evaluation of oxidative stress markers in chronic hepatitis C. Antioxidant Redox Signal 2004; 6: 19-24.
14. Lee Y-Y, Kim H-G, Jung H-I, Shin Y-H, Hong S-M, park E-H, et al. Activities of antioxidant and redox enzymes in human normal hepatic and hepatoma cell lines. Mol Cells 2002; 14: 305-11.
15. Nordberg J, Arner S J. Reactive oxygen species, antioxidants, and the mannmalian thioredoxin system. Free Radical Biol Med 2001; 31: 1287-1312.
16. Farinati F, Cardin R, Dgan P, De Maria N, Floyd R A, Van Thiel D H, et al. Oxidative DNA damage in circulating leukocytes occurs as an early event in chronic HCV infection. Free Radic Biol Med 1999; 27: 1284-91.
17. Cardin R, Saccoccio G, Masutti F, Bellentani S, Farinati F, Tiribelli C. DNA oxidative damage in leukocytes correlates with the severity of HCV-related liver disease: Validation in an open population study. J Hepatol 2001; 34: 587-92.
18. Loft S, Vistisen K, Ewertz M, Tjonneland A, Overad K, Poulsen H E. Oxidative DNA damage estimated by 8-hydroxyguansoine excretion in humans: Influence of smoking, gender and body mass index. Carcinogenesis 1992; 13: 2241-7.
19. Sumida Y, Nakashima T, Yoh T, Furutani M, Hirohama A, Kakisaka Y, et al. Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver diseases. J Hepatol 2003; 38: 32-8.
20. Yesilova Z, Yaman H, Oktenli C, Ozcan A, Uygun A, Cakir E, et al. Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease. Am J Gastroenterol 2005; 100: 850-5.
21. Kumar A, etzler E, Berger M. Isolation and characterization of complement receptor type 1 (CR1) storage vesicles from human neutrophils using antibodies to the cytoplasmic tail of CR1. Blood 1997; 89: 4555-65.
22. Evans M K, Cooke M S, Podmore I D, Zheng Q, Herbert K E, Lunec J. Discrepancies in the measurement of UV-induced 8-oxo-2′-deoxyguanosine: Implications for the analysis of oxidative DNA damage. Biochem Biophys Res Commun 1999; 259: 374-8.
23. Boya P, de la Pena A, Beloqui O, Conchillo M, Castelruiz Y, Civerira M-P, et al. Antioxidant status and glutathione metabolism in peripheral blood mononuclear cells from patients with chronic hepatitis C. J Hepatol 1999; 31: 808-14.
24. Bantel H, Lugering A, Heidemann J, Volkmann X, Poremba C, Strassburg C P, et al. Detection of apoptotic caspase activity in sera from patients with chronic HCV infection is associated with fibrotic liver injury. Hepatology 2004; 40: 1078-87.
25. Kumaraguruparan R, Kabalimoorthy J, Nagini S. Correlation of tissue lipid peroxidation and antioxidants with clinical stage and menopausal status in patients with adenocarcinoma of the breast. Clin Biochem 2005; 38: 154-8.
26. Gladyshev V N, Factor V M, Housseau F, Hatfield D L. Contrasting patterns of regulation of the antioxidant selenoproteins, thioredoxin reductase, and glutathione peroxidase, in cancer cells. Biochem Biophys Res Commun 1998; 251: 488-93.
27. Nordberg J, Arner E S J. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radical Biol Med 2001; 31: 1287-312.
28. Rubartelli A, Bonifaci N, Sitia R. High rates of thioredoxin secretion correlate with growth arrest in hepatoma cells. Cancer Res 1995; 55: 675-80.
29. Sumida Y, Nakashima T, Yoh T, Furutani M, Hirohama A, Kakisaka Y, et al. Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease. J Hepatol 2003; 38: 32-8.
30. Okuyama H, Nakamura H, Shimahara Y, Araya S, Kawada N, Yamaoka Y, et al. Overexpression of thioredoxin prevents acute hepatitis caused by thioacetamide or lipopolysaccharide in mice. Hepatology 2003; 37: 1015-25.
31. Allan C B, Lacourciere G M, Stadtman T C. Responsiveness of selenoproteins to dietary selenium. Ann Rev Nutr 1999; 19: 1-16.
32. Al-Taie O H, Uceyler N, EuSner U, Jakob F, Mork H, Scheurlen M, et al. Expression profiling and genetic alterations of the selenoproteins GI-gpx and sepp in colorectal carcinogenesis. Nutr Cancer 2004; 48: 6-14.
33. Tan M, Li S, Swaroop M, Guan K, Oberleys L W, Sun Y. Trancriptional activation of the human glutathione proxidase promoter by p53. J Biol Chem 1999; 274: 12061-6.
34. Bureau C, Bernard J, Chaouche N, Orfila C, Beraud M, Gonindard C, et al. Nonstructural 3 protein of hepatitis C virus triggers an oxidative burst in human monocytes via activation of NADPH oxidase. J Biol Chem 2001; 76: 23077-83.